(Reuters) - CVS Health Corp, the second-largest U.S. drugstore operator, will pay $22 million to resolve a federal probe into whether two of its pharmacies in central Florida sold powerful, potentially addictive painkillers that were not prescribed for legitimate medical purposes.
Continue reading
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.